Avalanche shares fall 56% but CEO won't say buy By: CNBC.com News June 17, 2015 at 12:36 PM EDT Avalanche Biotechnologies fell 56 percent, but CEO Thomas Chalberg declined to say whether he would buy more shares. Read More >> Related Stocks: Regeneron Pharmaceuticals